![]() Luigi could appeal for the said violation being a mistake, and he did. Though it was not specified which rules were violated by the tweet, it is likely that the content was marked for misinformation. A report on the tweet left Luigi with only an option of deleting it for violating Twitter Rules. The AP is solely responsible for all content.The appeal was to contest Twitter's decision to block the content from public view. The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. FDA’s advisers will debate that drug next month, too. European regulators recently approved the first one-dose option, from Sanofi and AstraZeneca, opening that type of protection to more infants. High-risk infants can get monthly doses of a protective drug during RSV season, although CDC data shows too few receive it. Vaccines aren’t the only advance in the pipeline. First, the CDC’s advisers will debate next month whether all older adults or only those at high risk need vaccination. Meanwhile, rival GSK is gearing up for fall immunizations with its RSV vaccine for seniors. Whether to use the same shot in pregnant women will be a separate FDA decision, expected in August. WHAT HAPPENS NEXT?įDA’s advisers already have recommended approving Pfizer’s vaccine for older adults, and the agency is expected to make a decision by month’s end. They pointed to data suggesting that a vaccine against whooping cough doesn’t seem as strong if pregnant women receive it at the same time as the RSV shot. ANOTHER OPEN QUESTIONįDA’s advisers also cautioned that it’s not clear which other vaccines given to pregnant women can be administered during the same doctor’s visit. Eventually scientists figured out the problem and the RSV vaccines in the pipeline today are made with safer, modern methods - yet still were tested first in older adults. Vaccines always get close safety scrutiny but regulators are especially mindful of a major setback in the 1960s when an experimental RSV shot worsened infections in children. Researchers deemed none of the deaths related to the vaccine but FDA said it “is unable to exclude the possibility” that one infant’s death, stemming from extreme prematurity, might be related. “There is certainty that the vaccine works and will keep infants out of the hospital in the United States as soon as this winter,” he said.Ī total of 17 infants died during the study, five born to vaccinated mothers and 12 to those given a dummy shot. ![]() William Gruber, Pfizer’s senior vice president, asked the panelists. “Do you hold hostage the potential benefits of the vaccine” without clear evidence of a problem, Dr. ![]() ![]() Pfizer said the preterm difference in its study was fueled by participants in South Africa - for unknown reasons - and there was no difference spotted in the U.S. At age 6 months, it still was proving 69% protective against severe illness.Ĭompetitor GSK halted its own trials of a maternal RSV vaccine because of prematurity concerns, spurring questions about Pfizer’s shot. In Pfizer’s international study of nearly 7,400 pregnant women, maternal vaccination proved 82% effective at preventing severe RSV during babies’ most vulnerable first three months of life. The idea: Give women a single injection late in pregnancy, between 24 weeks and 36 weeks, so they develop RSV-fighting antibodies that pass through the placenta - just like they pass protection against other bugs to their babies. Jay Portnoy, a member of the Food and Drug Administration advisory panel from Children’s Mercy Hospital in Kansas City, Missouri. If the vaccine pans out, “many infants and their parents will breathe easier in the coming years,” said Dr. RSV fills hospitals with wheezing babies each fall and winter, and the virus struck earlier than usual and especially hard in the U.S. WASHINGTON (AP) - A first-of-its-kind RSV vaccine for pregnant women guards their newborns against the scary respiratory virus -– and federal health advisers on Thursday backed Pfizer’s shot despite some lingering questions. ![]()
0 Comments
Leave a Reply. |